HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) An erratum has been published All Versions of this Article: 2005-0212v1 2005-0212v2 24/3/772    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints/Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Leor, J. Articles by Nagler, A. Search for Related Content PubMed PubMed Citation Articles by Leor, J. Articles by Nagler, A.

TRANSLATIONAL AND CLINICAL RESEARCH

Human Umbilical Cord Blood–Derived CD133⁺ Cells Enhance Function and Repair of the Infarcted Myocardium

^a Neufeld Cardiac Research Institute,
^b Danek Gertner Institute of Human Genetics, and
^c Hematology Division and Cord Blood Bank, Sheba Medical Center, Tel-Aviv University, Tel-Hashomer, Israel

Key Words. Aging • Heart • Myocardial infarction • Progenitor cells • Stem cells • Tissue therapy • Ventricular remodeling

Correspondence: Jonathan Leor, M.D., Neufeld Cardiac Research Institute, Sheba Medical Center, Tel-Hashomer 52621, Israel. Telephone: 972-3-534-8685; Fax: 972-3-535-1139; e-mail: leorj{at}post.tau.ac.il

Received May 11, 2005; accepted for publication September 19, 2005.
The use of adult stem cells for myocardial tissue repair might be limited in elderly and sick people because their cells are depleted and exhausted. The present study was conducted to explore the potential of human umbilical cord blood (UCB) CD133⁺ progenitor cells for myocardial tissue repair in a model of extensive myocardial infarction (MI). CD133⁺ progenitor cells were isolated from newborn UCB. Cells (1.2–2 x 10⁶) or saline (control) was infused intravenously 7 days after permanent coronary artery ligation in athymic nude rats. Left ventricular (LV) function was assessed before and 1 month after infusion by echocardiography. Tracking of human cells was performed by fluorescent in situ hybridization for human X and Y chromosomes or by immunostaining for HLA-DR or HLA-ABC. One month after delivery, LV fractional shortening improved by 42 ± 17% in cell-treated hearts and decreased by 39 ± 10% in controls (p = .001). Anterior wall thickness decreased significantly in controls but not in treated hearts. Microscopic examination revealed that the UCB cells were able to migrate, colonize, and survive in the infarcted myocardium. Human cells were identified near vessel walls and LV cavity and were occasionally incorporated into endothelial cells in six of nine cell-treated animals but not in controls. Scar tissue from cell-treated animals was significantly populated with autologous myofibroblasts as indicated by colocalization of HLA-DR and -smooth muscle actin staining. In conclusion, the present work suggests that, after MI, intravenous delivery of human UCB-derived CD133⁺ cells can produce functional recovery by preventing scar thinning and LV systolic dilatation.

This article has been cited by other articles:

				H. Reinecke, E. Minami, W.-Z. Zhu, and M. A. Laflamme Cardiogenic Differentiation and Transdifferentiation of Progenitor Cells Circ. Res., November 7, 2008; 103(10): 1058 - 1071. [Abstract] [Full Text] [PDF]

				J.-M. Pujal and D. Gallardo PCR-Based Methodology for Molecular Microchimerism Detection and Quantification Experimental Biology and Medicine, September 1, 2008; 233(9): 1161 - 1170. [Abstract] [Full Text] [PDF]

				J. Leor, S. Gerecht, S. Cohen, L. Miller, R. Holbova, A. Ziskind, M. Shachar, M. S Feinberg, E. Guetta, and J. Itskovitz-Eldor Human embryonic stem cell transplantation to repair the infarcted myocardium Heart, October 1, 2007; 93(10): 1278 - 1284. [Abstract] [Full Text] [PDF]

				N. Nishiyama, S. Miyoshi, N. Hida, T. Uyama, K. Okamoto, Y. Ikegami, K. Miyado, K. Segawa, M. Terai, M. Sakamoto, et al. The Significant Cardiomyogenic Potential of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells In Vitro Stem Cells, August 1, 2007; 25(8): 2017 - 2024. [Abstract] [Full Text] [PDF]